Related Experiment Video
Updated: Jun 21, 2026
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
Expression pattern of mda-7/IL-24 receptors in liver cancer cell lines
1Abdominal Cancer Centre, Third Affiliated Hospital, Kunming Medical College, Kunming 650102, China.
Background:
The mda-7/IL-24 receptor belongs to the type II cytokine receptor family, and its two heterodimeric receptors are IL-22R1/IL-20R2 and IL-20R1/IL-20R2. Mda-7/IL-24 receptor expression in liver cancer cell lines has not yet been described. This information may be helpful for further clinical gene therapy.
Methods:
With normal skin total RNA as template, the cDNA sequences of IL-20R1, IL-20R2 and IL-22R were amplified by RT-PCR. Total RNA was extracted from cultured liver cancer cell lines and a normal liver cell line, then detected by northern blotting, and the expression of mda-7/IL-24 receptors was analyzed.
Results:
PLC/PRF/5 and SMMC-7721 expressed IL-20R1; BEL-7402, Hep3B, HepG2, and PLC/PRF/5 expressed IL-20R2; and HepG2 and PLC/PRF/5 expressed IL-22R. Only HepG2 expressed the IL-22R/IL-20R2 receptor complex. PLC/PRF/5 completely expressed both heterodimeric receptors. Huh-7, QGY-7701 and WRL-68 did not express the IL-24 receptor.
Conclusion:
Complete mda-7/IL-24 receptors are seldom expressed in liver cancer cell lines.
Insights
The mda-7/interleukin-24 (IL-24) receptor, crucial for gene therapy, is rarely fully expressed in liver cancer cell lines. This limited expression impacts potential therapeutic applications targeting these receptors.
Area of Science:
- Molecular biology
- Oncology
- Genetics
Background:
- The mda-7/IL-24 receptor is part of the type II cytokine receptor family.
- It forms heterodimers with IL-22R1/IL-20R2 or IL-20R1/IL-20R2.
- Expression of this receptor in liver cancer is not well-documented.
Purpose of the Study:
- To investigate the expression of mda-7/IL-24 receptors in various liver cancer cell lines.
- To determine the presence of specific receptor subunits and heterodimers.
- To assess the potential for clinical gene therapy applications.
Main Methods:
- RT-PCR was used to amplify cDNA sequences for IL-20R1, IL-20R2, and IL-22R from normal skin.
- Total RNA was extracted from cultured liver cancer and normal liver cell lines.
- Northern blotting was employed to analyze receptor expression patterns.
Main Results:
- IL-20R1 was expressed in PLC/PRF/5 and SMMC-7721 cells.
- IL-20R2 was detected in BEL-7402, Hep3B, HepG2, and PLC/PRF/5 cells.
- IL-22R was found in HepG2 and PLC/PRF/5 cells, with HepG2 showing the IL-22R/IL-20R2 complex and PLC/PRF/5 expressing both heterodimeric receptors. Huh-7, QGY-7701, and WRL-68 cells lacked IL-24 receptor expression.
Conclusions:
- Complete expression of mda-7/IL-24 receptors is infrequent in liver cancer cell lines.
- This limited expression may pose challenges for gene therapy strategies.
- Further research is needed to understand the implications of these findings.
